lansoprazole has been researched along with Nephritis, Interstitial in 6 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Nephritis, Interstitial: Inflammation of the interstitial tissue of the kidney. This term is generally used for primary inflammation of KIDNEY TUBULES and/or surrounding interstitium. For primary inflammation of glomerular interstitium, see GLOMERULONEPHRITIS. Infiltration of the inflammatory cells into the interstitial compartment results in EDEMA, increased spaces between the tubules, and tubular renal dysfunction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Drug-induced interstitial nephritis is one of the causes of graft dysfunction in renal transplant recipients." | 5.38 | Lansoprazole-induced acute allergic interstitial nephritis in a renal transplant recipient: a case report. ( Aki, T; Baydar, DE; Kutlugun, AA; Turgan, C; Yildirim, T; Yilmaz, R, 2012) |
| "Acute tubulointerstitial nephritis (ATIN) has been increasingly recognized as an important manifestation of kidney injury associated with the use of immune checkpoint inhibitors (anti-PD-1 and anti-CTLA-4)." | 1.48 | Immune checkpoint inhibitor (nivolumab)-associated kidney injury and the importance of recognizing concomitant medications known to cause acute tubulointerstitial nephritis: a case report. ( Hasegawa, G; Iino, N; Imai, N; Koda, R; Narita, I; Suzuki, K; Tsuchida, M; Watanabe, H, 2018) |
| "Drug-induced interstitial nephritis is one of the causes of graft dysfunction in renal transplant recipients." | 1.38 | Lansoprazole-induced acute allergic interstitial nephritis in a renal transplant recipient: a case report. ( Aki, T; Baydar, DE; Kutlugun, AA; Turgan, C; Yildirim, T; Yilmaz, R, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koda, R | 1 |
| Watanabe, H | 1 |
| Tsuchida, M | 1 |
| Iino, N | 1 |
| Suzuki, K | 1 |
| Hasegawa, G | 1 |
| Imai, N | 1 |
| Narita, I | 1 |
| Jose, J | 1 |
| Saravu, K | 1 |
| Khera, K | 1 |
| Jimmy, B | 1 |
| Shastry, BA | 1 |
| Eken, J | 1 |
| Phadke, G | 1 |
| Ahmed, S | 1 |
| Mahale, A | 1 |
| Leung, N | 1 |
| Eirin, A | 1 |
| Irazabal, MV | 1 |
| Maddox, DE | 1 |
| Gunderson, HD | 1 |
| Fervenza, FC | 1 |
| Garovic, VD | 1 |
| Yildirim, T | 1 |
| Yilmaz, R | 1 |
| Baydar, DE | 1 |
| Kutlugun, AA | 1 |
| Aki, T | 1 |
| Turgan, C | 1 |
| Torpey, N | 1 |
| Barker, T | 1 |
| Ross, C | 1 |
6 other studies available for lansoprazole and Nephritis, Interstitial
| Article | Year |
|---|---|
Immune checkpoint inhibitor (nivolumab)-associated kidney injury and the importance of recognizing concomitant medications known to cause acute tubulointerstitial nephritis: a case report.
Topics: Acute Kidney Injury; Aged; Antineoplastic Agents, Immunological; Carcinoma, Non-Small-Cell Lung; Dru | 2018 |
Acute interstitial nephritis related to lansoprazole administration.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Aged; Anti-Ulcer Agents; Female; Humans; Lan | 2008 |
Lansoprazole-induced acute interstitial nephritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Humans; Lansoprazole; Male; Nephri | 2009 |
Acute kidney injury in patients with inactive cytochrome P450 polymorphisms.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Kidney Injury; Anti-Ulcer Agents; Antiemetics; Aryl H | 2009 |
Lansoprazole-induced acute allergic interstitial nephritis in a renal transplant recipient: a case report.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Drug Hypersensitivity; Female; Humans; K | 2012 |
Drug-induced tubulo-interstitial nephritis secondary to proton pump inhibitors: experience from a single UK renal unit.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Creatinine; Enzyme Inhibitors; Fem | 2004 |